If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
32
Followers on Owler
Nuvectra
focuses on developing Spinal Cord Stimulation system for the treatment of chronic disorders...
Read more
Overview
Competitors
Funding
News & Insights
Nuvectra
focuses on developing Spinal Cord Stimulation system for the treatment of chronic disorders...
Read more
CEO
Fred Parks
CEO Approval Rating
84/100
Weigh In
2008
Plano
Texas
Dallas-fort Worth Metropolitan Area
Public
NASDAQ
NVTR
Health Care Equipment & Services
Health Care Technology
8090
NAICS listing
http://nuvectramed.com/
Annual Revenue
$48.3M
Employees
197
Funding
$45M
News
Latest News
Mar 22, 2020
Zolmax News
Nuvectra: Reviewing Nuvectra (OTCMKTS:NVTRQ) & Titan Medical (OTCMKTS:TMDI)
Mar 22, 2020
themarketsdaily
Nuvectra: Titan Medical (NASDAQ:TMDI) versus Nuvectra (NASDAQ:NVTRQ) Critical Comparison
Mar 17, 2020
BioPortfolio
Nuvectra: Cirtec Announces Acquisition of Intellectual Property to Support Neurostimulation R&D Platform
Mar 16, 2020
Market Exclusive
Nuvectra: Nuvectra Corporation (NASDAQ:NVTR) Files An 8-K Financial Statements and Exhibits
Jan 05, 2020
Zolmax News
Nuvectra: Millennium Management LLC Sells 481,357 Shares of Nuvectra Corp (NASDAQ:NVTR)
Nov 22, 2019
Market Exclusive
Nuvectra: Nuvectra Corporation (NASDAQ:NVTR) Files An 8-K Costs Associated with Exit or Disposal Activities
Nov 14, 2019
Market Exclusive
Nuvectra: Nuvectra Corporation (NASDAQ:NVTR) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Nov 13, 2019
FE Investegate
Nuvectra: Nuvectra : Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11
Oct 18, 2019
centralcharts
Press Release: Nuvectra : Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis
Sep 20, 2019
Market Exclusive
Nuvectra: Nuvectra Corporation (NASDAQ:NVTR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Follow and Get Alerts
Nuvectra Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 15 + competitors
Trending Companies